Latham & Watkins LLP represented CytomX in the transaction. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and CytomX Therapeutics, Inc. (NASDAQ: CTMX) have announced a collaboration and licensing...
CytomX’s Collaboration and Licensing Agreement With Regeneron Pharmaceuticals
Bending Spoons’ Acquisition of Evernote
Latham & Watkins represented Evernote in the transaction. Willkie advised Bending Spoons. Bending Spoons, a leading European technology company, has announced an agreement to acquire Evernote,...
Vaxcyte’s $690 Million Public Offering
Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...
Orbital Therapeutics’ Partnership With Beam Therapeutics
Latham & Watkins advised Orbital Therapeutics on the deal. Orbital Therapeutics, which aims to enhance global health by unleashing the full potential of RNA medicine, announced...
Material Bank’s $175 Million Series D Funding
WilmerHale advised General Catalyst, while Latham & Watkins represented Brookfield, the lead investor, in the financing round. Fenwick advised Material Bank. Material Bank, a digital marketplace...
Cloudflare’s $162 Million Acquisition of Area 1 Security
Latham & Watkins represented Area 1 Security in the transaction. Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, has...
Spirit Airlines’ $6.6 Billion Merger with Frontier Airlines
Debevoise & Plimpton advised Spirit Airlines, while Latham & Watkins represented Frontier in the transaction. Fried Frank acted as counsel to Citigroup Global Markets Inc. as...
Plaid’s Acquisition of Cognito
Latham & Watkins represented Plaid in the transaction. Plaid executed the acquisition of Cognito, an identity verification and compliance (KYC, AML) platform that makes it faster, easier,...
Neumora Therapeutics’ Collaboration With Amgen
Latham & Watkins represented Neumora in the deal. Amgen and Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering precision medicines for brain diseases, announced a strategic collaboration...
Rivian Automotive’s Initial Public Offering
Latham & Watkins advised Rivian Automotive, while Skadden, Arps, Slate, Meagher & Flom advised the underwriters in the Initial Public Offering. Rivian Automotive, Inc. has announced its...
Agenus’ Launch of SaponiQx
Latham & Watkins represented Agenus Inc. in the transaction. Agenus Inc. (Agenus), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines...
Phononic’s $50 Million Growth Investment
Latham & Watkins represented Phononic in the transaction. Phononic, a global leader in sustainable solid-state cooling and heating technology, has secured a significant growth investment of...